BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7850723)

  • 1. Myelopathy after intrathecal chemotherapy: a case report with unique magnetic resonance imaging changes.
    López-Andreu JA; Ferrís J; Verdeguer A; Esquembre C; Castel V
    Cancer; 1995 Mar; 75(5):1216-7. PubMed ID: 7850723
    [No Abstract]   [Full Text] [Related]  

  • 2. Lumbosacral polyradiculopathy after intrathecal chemotherapy in pediatric acute lymphoblastic leukemia.
    Suematsu M; Imamura T; Chiyonobu T; Osone S; Hosoi H
    Int J Hematol; 2018 May; 107(5):499-501. PubMed ID: 29470812
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia.
    García-Tena J; López-Andreu JA; Ferrís J; Menor F; Mulas F; Millet E; Verdeguer A
    Pediatr Hematol Oncol; 1995; 12(4):377-85. PubMed ID: 7577390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
    Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
    World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myelopathy due to intrathecal chemotherapy in a patient with acute lymphoblastic leukemia].
    Piernas S; Sancho JM; Batlle M; Ribera JM
    Med Clin (Barc); 2006 Jan; 126(2):76. PubMed ID: 16426550
    [No Abstract]   [Full Text] [Related]  

  • 7. Language skills in a child with Leber hereditary optic neuropathy following intrathecal chemotherapy for acute lymphoblastic leukemia.
    Lewis FM; Coman DJ; Murdoch BE
    Pediatr Hematol Oncol; 2010 Nov; 27(8):626-35. PubMed ID: 20795771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
    Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
    Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
    Wang Z; Xu W; Liu L; Ding Z
    Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
    [No Abstract]   [Full Text] [Related]  

  • 12. Transverse myelopathy following intrathecal administration of chemotherapy.
    Teh HS; Fadilah SA; Leong CF
    Singapore Med J; 2007 Feb; 48(2):e46-9. PubMed ID: 17304378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure motor lumbosacral radiculopathy after intrathecal chemotherapy.
    Santos-García D; Pardo J; Vázquez F; Rabuñal-Martínez MJ; Martín-Vigo AI; de la Fuente-Fernández R
    Eur J Neurol; 2008 Aug; 15(8):e86-7. PubMed ID: 18549396
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Uchimaru K; Tojo A
    Intern Med; 2008; 47(22):1987-8. PubMed ID: 19015613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive paresthesia and weakness after intrathecal chemotherapy.
    Marshall R; Gupta ND; Palacios E; Neitzschman HR
    J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
    Gollard RP; Selco S
    J Clin Oncol; 2013 Jul; 31(19):e327-31. PubMed ID: 23715575
    [No Abstract]   [Full Text] [Related]  

  • 17. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.
    Henderson RD; Rajah T; Nicol AJ; Read SJ
    Neurology; 2003 Jan; 60(2):326-8. PubMed ID: 12552054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
    Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
    Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes.
    McLean DR; Clink HM; Ernst P; Coates R; al Kawi MZ; Bohlega S; Omer S
    Cancer; 1994 Jun; 73(12):3037-40. PubMed ID: 8200001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.